HRT, explained without the fear

A whole generation of women was denied hormone therapy because of one misread headline. Here's what the research actually says.

6 minute read

Here's what happened. In 2002, a study called the Women's Health Initiative made global headlines saying hormone therapy caused breast cancer. Doctors stopped prescribing it almost overnight. A generation of women suffered through perimenopause and menopause untreated because of one scary number.

The problem: that study was on women who started HRT in their 60s, on average a decade or more past menopause. They were also on an older, higher-dose, synthetic formulation. The risk profile for a 45-year-old starting modern bioidentical HRT is not the same risk profile. It's not even close.

What we actually know now

For most women who start HRT within 10 years of menopause, or before age 60, the research supports meaningful benefits: relief from hot flashes and night sweats, better sleep, better mood, protection against osteoporosis, and likely reduced risk of heart disease.

Breast cancer risk on modern HRT is small — smaller than the increase from drinking two glasses of wine a night, and smaller than the increase from being overweight. That doesn't mean zero. It means it's a real decision, not a forbidden one.

What "modern HRT" actually means

• Estradiol patches or gels instead of oral pills — skips the liver, lower clot risk
• Micronized progesterone (same molecule your body makes) instead of synthetic progestin
• Low doses titrated to your symptoms, not a one-size number

Who shouldn't take it

Women with a history of hormone-sensitive breast cancer, certain clotting disorders, unexplained vaginal bleeding, or active liver disease need a different conversation. This is where a real clinician — not a questionnaire — matters.